Economic Impact of Early Detection and Early Intervention of Psychosis

Title: Economic Impact of Early Detection and Early Intervention of Psychosis

Volume: 18 Issue: 4

Author(s): Lucia R. Valmaggia, Philip K McGuire, Paolo Fusar-Poli, Oliver Howes and Paul McCrone

Affiliation:

Keywords: Early detection, early intervention, costs, at risk mental state, psychosis, cognitive therapy group, prodromal symptoms, psychotic symptoms, social psychiatry patients, relapse rate

Abstract: Background: Whilst there is a growing body of evidence relating to the effectiveness of early detection and early intervention services there have been relatively few studies which have provided information on whether they are cost-effective. Aim: The aim of this paper is to review the cost-effectiveness evidence for early detection and early intervention in psychosis. Methods: Full economic evaluations, cost studies, and studies which do not report costs but do provide important resource use information were included in the review. Results: All cost effectiveness analysis to date suggest that it is possible to offer help early in the development of psychosis in a cost effective manner. Conclusions: The potential longer term economic benefits of early detection and early intervention are required.

Cite this article as:

R. Valmaggia Lucia, K McGuire Philip, Fusar-Poli Paolo, Howes Oliver and McCrone Paul, Economic Impact of Early Detection and Early Intervention of Psychosis, Current Pharmaceutical Design 2012; 18 (4) . https://dx.doi.org/10.2174/138161212799316145